Back to Comparisons
Product Comparison

MDHearing Neo XS vs Nuheara IQBuds Max

Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Uses Official HearAdvisor Lab Data
MDHearing Neo XS Hero
MDHearingSoundScore 2.9Grade C

MDHearing Neo XS

The MDHearing Neo XS is a budget OTC hearing aid featuring an invisible-in-ear design, priced at $397. In our lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 devices in the OTC hearing aid category. This device presents a mixed performance profile. Its standout strength is excellent feedback handling at 5.0/5, scoring 0.46 points above the category average—meaning users should experience minimal whistling or squealing during everyday use. Own-voice comfort is also solid at 3.2/5, sitting 0.69 points above average, which suggests the device manages occlusion reasonably well for its invisible design. However, speech clarity is a significant weakness. Speech in quiet scored just 1.0/5, falling 1.77 points below the category average, while speech in noise scored 1.0/5, sitting 0.48 points below average. Music streaming scored 0.0/5, coming in 1.92 points below average—indicating this device is not suitable for audio entertainment. These low absolute scores mean users may struggle to achieve meaningful speech benefit in our standardized test conditions. The invisible-in-ear form factor and rechargeable batteries offer convenience, but buyers should weigh this against the limited speech performance. Several competitors in the same price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—deliver substantially better sound quality. The Neo XS may appeal to those prioritizing discretion and feedback-free wear over speech clarity, but most users seeking improved communication would benefit from exploring higher-performing alternatives.

Nuheara IQBuds Max Hero
NuhearaSoundScore 3.3Grade B

Nuheara IQBuds Max

The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in our lab testing. Priced at $499, this visible-in-ear device from 2021 ranks #46 of 65 OTC hearing aids tested, placing it in the top 69% of its category. The standout feature of the IQBuds Max is its exceptional music streaming performance, scoring 4.3/5—a strong result that sits 2.38 points above the category average. For users who prioritize audio entertainment alongside hearing assistance, this device delivers notably better streaming fidelity than most OTC alternatives. However, speech performance presents a mixed picture. Speech in quiet scores 2.0/5, falling 0.78 points below the category average. Speech in noise is essentially at par with competitors at 1.5/5, which is above average for the category but low in absolute terms. Own voice comfort also trails the category average by 0.31 points with a score of 2.2/5. Feedback handling scores a solid 3.4/5 in absolute terms, though this falls 1.14 points below the category average. The IQBuds Max is best suited for users who value music and audio streaming quality over speech clarity, particularly those seeking an affordable entry point into amplification. Competing devices in this price range—including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5)—offer stronger overall sound performance for similar investment.

Performance metrics

Scale 1-5 (Tuned)

Lab metric by fit

Scale 1-5 (Tuned)

Speech in quietNew
MDHearing Neo XS1.0
Nuheara IQBuds Max2.0
Speech in noiseNew
MDHearing Neo XS1.0
Nuheara IQBuds Max1.5
Own voice
MDHearing Neo XS3.2
Nuheara IQBuds Max2.2
Feedback handling
MDHearing Neo XS5.0
Nuheara IQBuds Max3.4
Music streaming
MDHearing Neo XS0.0
Nuheara IQBuds Max4.3
Overall fit score
MDHearing Neo XS2.9
Nuheara IQBuds Max3.4

Speech level

Adjust input dB (Tuned)

Amplification (REIG)

Insertion gain at 65 dB (Tuned)

Fitting configuration for tuned fit

MDHearing Neo XSNuheara IQBuds Max
Ear CouplingSleeve Vented
Ear CouplingClosed Dome